AAAAAA
Results:
1-11
|
Results: 11
Authors:
Andreone, P
Gramenzi, A
Cursaro, C
Biselli, M
Di Giammarino, L
Grazi, GL
Jovine, E
D'Errico, A
Galli, S
Mazziotti, A
Cavallari, A
Bernardi, M
Citation: P. Andreone et al., Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study, DIG LIVER D, 33(8), 2001, pp. 693-697
Authors:
Andreone, P
Cursaro, C
Gramenzi, A
Margotti, M
Ferri, E
Talarico, S
Biselli, M
Felline, F
Tuthill, C
Martins, E
Gasbarrini, G
Bernardi, M
Citation: P. Andreone et al., In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C, J VIRAL HEP, 8(3), 2001, pp. 194-201
Authors:
Andreone, P
Fiorino, S
Cursaro, C
Gramenzi, A
Margotti, M
Di Giammarino, L
Biselli, M
Miniero, R
Gasbarrini, G
Bernardi, M
Citation: P. Andreone et al., Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial, ANTIVIR RES, 49(2), 2001, pp. 75-81
Authors:
Gramenzi, A
Andreone, P
Fiorino, S
Camma, C
Giunta, M
Magalotti, D
Cursaro, C
Calabrese, C
Arienti, V
Rossi, C
Di Febo, G
Zoli, M
Craxi, A
Gasbarrini, G
Bernardi, M
Citation: A. Gramenzi et al., Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis, GUT, 48(6), 2001, pp. 843-848
Authors:
Andreone, P
Gramenzi, A
Cursaro, C
Bernardi, M
Citation: P. Andreone et al., Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alpha efficacy in chronic hepatitis C: don't lose the tract!, DIG LIVER D, 32(6), 2000, pp. 542-543
Authors:
Foschi, FG
Gramenzi, A
Castelli, E
Cursaro, C
Pagani, S
Margotti, M
D'Errico, A
Andreone, P
Stefanini, GF
Bernardi, M
Citation: Fg. Foschi et al., Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?, CYTOKINE, 12(6), 2000, pp. 815-818
Authors:
Lok, ASF
Hussain, M
Cursano, C
Margotti, M
Gramenzi, A
Grazi, GL
Jovine, E
Benardi, M
Andreone, P
Citation: Asf. Lok et al., Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy, HEPATOLOGY, 32(5), 2000, pp. 1145-1153
Authors:
De Mitri, RS
Mele, L
Morsica, G
Chen, CH
Sitia, G
Gramenzi, A
Andreone, P
Alberti, A
Bernardi, N
Pisi, E
Citation: Rs. De Mitri et al., Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies, J MED VIROL, 60(2), 2000, pp. 133-138
Authors:
Andreone, P
Cursaro, C
Gramenzi, A
Fiorino, S
Di Ciammarino, L
Miniero, R
D'Errico, A
Grigioni, WF
Gasbarrini, G
Bernardi, M
Citation: P. Andreone et al., Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study, ITAL J GAST, 31(8), 1999, pp. 688-694
Authors:
Andreone, P
Gramenzi, A
Cursaro, C
Sbolli, G
Fiorino, S
Di Giammarino, L
Miniero, R
D'Errico, A
Gasbarrini, G
Bernardi, M
Citation: P. Andreone et al., Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial, J HEPATOL, 30(5), 1999, pp. 788-793
Authors:
Pezzilli, R
Andreone, P
Morselli-Labate, AM
Sama, C
Billi, P
Cursaro, C
Barakat, B
Gramenzi, A
Fiocchi, M
Miglio, F
Bernardi, M
Citation: R. Pezzilli et al., Serum pancreatic enzyme concentrations in chronic viral liver diseases, DIG DIS SCI, 44(2), 1999, pp. 350-355
Risultati:
1-11
|